Myths vs facts: ADH1B and gut health

ADH1B encodes alcohol dehydrogenase, which metabolizes ethanol. Certain variants (e.g., rs1229984) increase the rate of alcohol-to-acetaldehyde conversion, linked to lower alcohol dependence risk. The claim that ADH1B variants directly improve gut health is a myth. No strong human trials show a causal effect on microbiome composition or intestinal barrier function. Some observational studies suggest indirect effects via altered drinking behavior, but that is not a direct gut-health benefit. Evidence is weak (GWAS associations, no clinical validation). Consumers should not rely on single genes for gut health; lifestyle, diet, and comprehensive microbiome testing are more informative.